Robinhood’s crypto transaction income soars 232% from a 12 months in the past: CNBC Crypto World

Robinhood’s crypto transaction income soars 232% from a 12 months in the past: CNBC Crypto World


Share

CNBC Crypto Globe functions the hottest information and daily investing updates from the digital forex marketplaces and delivers viewers with a glance at what is forward with significant-profile interviews, explainers, and distinctive tales from the ever-shifting crypto industry. On today’s demonstrate, Lou Frangella, head of manufacturer partnerships at Kraken, discusses why the crypto exchange is wanting to Formula 1 followers to increase crypto adoption.



Source

Intel soars 14% on report of Apple chip talks, hits new all-time high
World

Intel soars 14% on report of Apple chip talks, hits new all-time high

Intel headquarters in Santa Clara, California, on Jan. 22, 2026. Justin Sullivan | Getty Images Intel shares climbed 14% Tuesday, hitting a new all-time high as the chipmaker continued its historic run from April. The jump comes on a Bloomberg report that Apple is in talks with both Intel and Samsung to produce the main […]

Read More
AI productivity gains, the case for Europe & underweight Japan: Three investment strategies from the studio
World

AI productivity gains, the case for Europe & underweight Japan: Three investment strategies from the studio

U.S. futures are trending to the upside, as investors eye developments in the Middle East, with crude prices dipping. In Europe, stocks are also seeing the upside, with only the FTSE 100, where oil majors such as BP and Shell trade, in the red. Here are three investment strategies we heard in CNBC’s Singapore and […]

Read More
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
World

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as its recently launched and acquired products showed growth. Older top-selling drugs, including its blood thinner […]

Read More